Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Avinger (NASDAQ:AVGRGet Free Report) in a report released on Sunday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR opened at $0.47 on Friday. The firm’s 50-day moving average is $0.47 and its two-hundred day moving average is $0.65. Avinger has a twelve month low of $0.36 and a twelve month high of $4.15. The firm has a market capitalization of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Further Reading

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.